Agency Forms Undergoing Paperwork Reduction Act Review, 5101-5102 [2018-02205]

Download as PDF Federal Register / Vol. 83, No. 24 / Monday, February 5, 2018 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES 395–5806. Provide written comments within 30 days of notice publication. Centers for Disease Control and Prevention Proposed Project Implementing the 6|18 Initiative: Case Studies—New—Office of the Director (OD), Centers for Disease Control and Prevention (CDC). [30Day–18–17BAM] sradovich on DSK3GMQ082PROD with NOTICES Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled Implementing the 6/18 Initiative: Case Studies to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on October 13, 2017 to obtain comments from the public and affected agencies. CDC did not receive comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) VerDate Sep<11>2014 18:08 Feb 02, 2018 Jkt 244001 Background and Brief Description Major trends in health care, such as alternative payment and delivery models, facilitate the delivery of greater comprehensive care and prevention. Public health departments have leveraged their resources to complement those of the health care sector, to impact population health. In this context, CDC developed the CDC’s 6|18 Initiative to provide health care purchasers, payers, and providers with rigorous evidence about highburden health conditions and associated evidence-based interventions. With a focus on the greatest short-term health and potential cost impact (generally in less than five years), the evidence informs their coverage decisions. The name ‘‘6|18’’ comes from the initial focus on six common, costly and preventable health conditions (tobacco use, high blood pressure, diabetes, asthma, healthcare-associated infections and unintended pregnancies) and 18 evidence-based interventions. For more information, please see https:// www.cdc.gov/sixeighteen. The 6|18 initiative links health care and public health by providing a shared focus across prevention interventions ranging from traditional clinical settings to care outside the clinical setting. Public health’s strength in analyzing scientific evidence complements the purchaser, payer, and provider role of financing and delivering care. Since public health-health care collaboration to improve population health is still not a standard practice, there are few or no case studies on public health-health care collaboration around increasing preventive service utilization. CDC intends to fill this gap through this data collection. CDC and its partners provided technical assistance to 17 teams (i.e., from Medicaid and Public Health Agencies) from states, the District of Columbia, and a large city (hereafter, ‘‘states’’), to support their implementation of the 6|18 Initiative’s interventions. No data has been collected to date. To document qualitative lessons learned related to the collaboration, CDC and its cooperative agreement subcontractor, George Washington University, plan to conduct in-person and telephone semi-structured PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 5101 individual interviews with state Public Health Department and State Medicaid Agency officials. Interview participants will have been directly involved in conceptualizing, planning, and/or implementing 6|18 Initiative-related activities, and will have participated in the cross-sector collaboration. CDC plans to engage up to 82 respondents (four to seven officials from each of the 17 state teams who participated in the 6|18 Initiative). The officials from each state team will be leadership and staff from public health agencies at the state, city, and tribal level. For each state, we will request interviews with: One Public Health Division Director, one to four Public Health Services Managers (one per health condition), one Medicaid Director, and one Medicaid Services Manager. When joining the 6|18 Initiative, each state selected one to four conditions from the list of 6|18 conditions, and assigned one public health manager to each condition. CDC plans to administer the interviews from 2018 to 2021, to allow time for unanticipated delays; and to accommodate state team schedules, busy seasons, and holidays. All participants will speak in their official capacity as state public health department or Medicaid agency officials. Prior to granting public access to written products, CDC will provide participants the opportunity to review written products. CDC anticipates using the interview findings: (1) To describe, disseminate, and scale best practices to participating and non-participating states, and (2) for program improvement of the CDC’s 6|18 Initiative. CDC will disseminate findings via written products such as peer-reviewed manuscripts and indepth written case studies. The written products, which will share lessons learned and effective approaches to collaboration, can inform and potentially accelerate related efforts by other state teams. In addition, 6|18 participants can use findings and written products to highlight their accomplishments to their stakeholders, such as their Medicaid leadership, and/ or governors. Participants will have a maximum estimated burden of one hour and 15 minutes: One hour for the interview, and fifteen minutes for any needed preparation. All interviews will be based on the same interview guide. OMB approval is requested for three years. An annualized average of 29 interviews will be conducted per year. Participation is voluntary and respondents will not receive incentives for participation. There are no costs to E:\FR\FM\05FEN1.SGM 05FEN1 5102 Federal Register / Vol. 83, No. 24 / Monday, February 5, 2018 / Notices respondents other than their time. The total estimated annualized burden hours are 38. ESTIMATED ANNUALIZED BURDEN HOURS Type of respondents State State State State Public Health Director ........................... Public Health Manager .......................... Medicaid Director .................................. Medicaid Manager ................................. Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2018–02205 Filed 2–2–18; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES [60Day–18–0307; Docket No. CDC–2018– 0019] Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled ‘‘Gonococcal Isolate Surveillance Project (GISP)’’. The purpose of GISP is to monitor trends in antimicrobial resistance in N. gonorrhoeae strains in the United States in order to establish a scientific basis for the selection of gonococcal therapies and to allow proactive changes to treatment guidelines before widespread resistance and failures of treatment occur. DATES: CDC must receive written comments on or before April 6, 2018. ADDRESSES: You may submit comments, identified by Docket No. CDC–2018– 0019 by any of the following methods: sradovich on DSK3GMQ082PROD with NOTICES Jkt 244001 .............................................. .............................................. .............................................. .............................................. • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329. To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including FOR FURTHER INFORMATION CONTACT: Proposed Data Collection Submitted for Public Comment and Recommendations 18:08 Feb 02, 2018 Guide Guide Guide Guide Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. Centers for Disease Control and Prevention VerDate Sep<11>2014 Interview Interview Interview Interview Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to Regulations.gov. BILLING CODE 4163–18–P SUMMARY: Number of respondents Form name PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 6 11 6 6 Number of responses per respondent Average burden per response (in hours) 1 1 1 1 75/60 75/60 75/60 75/60 whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. 5. Assess information collection costs. Proposed Project Gonococcal Isolate Surveillance Project (OMB Control Number 0920– 0307, Expiration 2/28/2019)— Revision—National Center for HIV/ AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Gonococcal Isolate Surveillance Project (GISP) was created in 1986 to monitor trends in antimicrobial susceptibilities of N. gonorrhoeae strains in the United States. Data from GISP are used to establish a scientific basis for the selection of gonococcal therapies and to allow pro-active changes to treatment guidelines before widespread resistance and failures of treatment occur. To increase capacity to detect and monitor resistant gonorrhea and improve the specificity of GISP, this submission is a revision to include collection of additional isolates and data elements. The Centers for Disease Control and Prevention has designated N. gonorrhoeae as one of three ‘‘urgent’’ antibiotic resistance threats in the United States. The CDC is requesting a three-year OMB approval for this revision, which directly responds to the E:\FR\FM\05FEN1.SGM 05FEN1

Agencies

[Federal Register Volume 83, Number 24 (Monday, February 5, 2018)]
[Notices]
[Pages 5101-5102]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02205]



[[Page 5101]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-18-17BAM]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled Implementing the 6/18 Initiative: Case 
Studies to the Office of Management and Budget (OMB) for review and 
approval. CDC previously published a ``Proposed Data Collection 
Submitted for Public Comment and Recommendations'' notice on October 
13, 2017 to obtain comments from the public and affected agencies. CDC 
did not receive comments related to the previous notice. This notice 
serves to allow an additional 30 days for public and affected agency 
comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Direct written comments 
and/or suggestions regarding the items contained in this notice to the 
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th 
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide 
written comments within 30 days of notice publication.

Proposed Project

    Implementing the 6[bond]18 Initiative: Case Studies--New--Office of 
the Director (OD), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Major trends in health care, such as alternative payment and 
delivery models, facilitate the delivery of greater comprehensive care 
and prevention. Public health departments have leveraged their 
resources to complement those of the health care sector, to impact 
population health.
    In this context, CDC developed the CDC's 6[bond]18 Initiative to 
provide health care purchasers, payers, and providers with rigorous 
evidence about high-burden health conditions and associated evidence-
based interventions. With a focus on the greatest short-term health and 
potential cost impact (generally in less than five years), the evidence 
informs their coverage decisions.
    The name ``6[bond]18'' comes from the initial focus on six common, 
costly and preventable health conditions (tobacco use, high blood 
pressure, diabetes, asthma, healthcare-associated infections and 
unintended pregnancies) and 18 evidence-based interventions. For more 
information, please see https://www.cdc.gov/sixeighteen.
    The 6[bond]18 initiative links health care and public health by 
providing a shared focus across prevention interventions ranging from 
traditional clinical settings to care outside the clinical setting. 
Public health's strength in analyzing scientific evidence complements 
the purchaser, payer, and provider role of financing and delivering 
care.
    Since public health-health care collaboration to improve population 
health is still not a standard practice, there are few or no case 
studies on public health-health care collaboration around increasing 
preventive service utilization. CDC intends to fill this gap through 
this data collection.
    CDC and its partners provided technical assistance to 17 teams 
(i.e., from Medicaid and Public Health Agencies) from states, the 
District of Columbia, and a large city (hereafter, ``states''), to 
support their implementation of the 6[bond]18 Initiative's 
interventions. No data has been collected to date.
    To document qualitative lessons learned related to the 
collaboration, CDC and its cooperative agreement sub-contractor, George 
Washington University, plan to conduct in-person and telephone semi-
structured individual interviews with state Public Health Department 
and State Medicaid Agency officials.
    Interview participants will have been directly involved in 
conceptualizing, planning, and/or implementing 6[bond]18 Initiative-
related activities, and will have participated in the cross-sector 
collaboration. CDC plans to engage up to 82 respondents (four to seven 
officials from each of the 17 state teams who participated in the 
6[bond]18 Initiative). The officials from each state team will be 
leadership and staff from public health agencies at the state, city, 
and tribal level. For each state, we will request interviews with: One 
Public Health Division Director, one to four Public Health Services 
Managers (one per health condition), one Medicaid Director, and one 
Medicaid Services Manager. When joining the 6[bond]18 Initiative, each 
state selected one to four conditions from the list of 6[bond]18 
conditions, and assigned one public health manager to each condition.
    CDC plans to administer the interviews from 2018 to 2021, to allow 
time for unanticipated delays; and to accommodate state team schedules, 
busy seasons, and holidays. All participants will speak in their 
official capacity as state public health department or Medicaid agency 
officials. Prior to granting public access to written products, CDC 
will provide participants the opportunity to review written products.
    CDC anticipates using the interview findings: (1) To describe, 
disseminate, and scale best practices to participating and non-
participating states, and (2) for program improvement of the CDC's 
6[bond]18 Initiative. CDC will disseminate findings via written 
products such as peer-reviewed manuscripts and in-depth written case 
studies. The written products, which will share lessons learned and 
effective approaches to collaboration, can inform and potentially 
accelerate related efforts by other state teams. In addition, 6[bond]18 
participants can use findings and written products to highlight their 
accomplishments to their stakeholders, such as their Medicaid 
leadership, and/or governors.
    Participants will have a maximum estimated burden of one hour and 
15 minutes: One hour for the interview, and fifteen minutes for any 
needed preparation. All interviews will be based on the same interview 
guide.
    OMB approval is requested for three years. An annualized average of 
29 interviews will be conducted per year. Participation is voluntary 
and respondents will not receive incentives for participation. There 
are no costs to

[[Page 5102]]

respondents other than their time. The total estimated annualized 
burden hours are 38.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
        Type of respondents                   Form name             respondents   responses  per   response  (in
                                                                                     respondent       hours)
----------------------------------------------------------------------------------------------------------------
State Public Health Director.......  Interview Guide............               6               1           75/60
State Public Health Manager........  Interview Guide............              11               1           75/60
State Medicaid Director............  Interview Guide............               6               1           75/60
State Medicaid Manager.............  Interview Guide............               6               1           75/60
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-02205 Filed 2-2-18; 8:45 am]
 BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.